NCT06564181

Brief Summary

The goal of this observational study is to investigate the relation between serum zinc and lupus nephritis by search Prevalence of hypozincemia in lupus nephritis and Association between serum zinc and urea, serum creatinine, hemoglobin, estimated glomerular filtration rate (eGFR).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Oct 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
2.1 years until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

August 19, 2024

Last Update Submit

December 27, 2025

Conditions

Lupus Nephritis

Outcome Measures

Primary Outcomes (1)

  • Prevalence of hypozincemia in lupus nephritis Correlation between hypozincemia and urea , S. Creatinine and eGFR

    Prevalence of hypozincemia in lupus nephritis

    1/9/2024 - 1/9/2025

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Patient with lupus nephritis . * patients with sex and age matching health control ( control group)

You may qualify if:

  • Patients with lupus nephritis

You may not qualify if:

  • other patients with other renal diseases .
  • patients with other autoimmune diseases.
  • patients on dialysis.
  • patients with Diabetes mellitus.
  • patients with liver diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lupus Nephritis

Condition Hierarchy (Ancestors)

GlomerulonephritisNephritisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLupus Erythematosus, SystemicConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Yasser Abdel Mawgoud, Dr

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Ahmed Ashraf

CONTACT

+201140198081Ahmed.16266353@med.aun.edu.eg

Rania Mohammed, Pro

CONTACT

+201000019198raniahafez@aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 19, 2024

First Posted

August 21, 2024

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 2, 2026

Record last verified: 2025-12